GSK Plc (GSK)
49.02
+1.15
(+2.40%)
USD |
NYSE |
Oct 15, 16:00
49.02
0.00 (0.00%)
After-Hours: 20:00
GSK Total Return Price : 49.02 for Oct. 15, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 14, 2026 | 47.87 |
| October 13, 2026 | 46.27 |
| October 12, 2026 | 46.92 |
| October 09, 2026 | 46.50 |
| October 08, 2026 | 46.54 |
| October 07, 2026 | 47.02 |
| October 06, 2026 | 46.60 |
| October 05, 2026 | 46.55 |
| October 02, 2026 | 47.03 |
| October 01, 2026 | 47.18 |
| September 30, 2026 | 48.17 |
| September 29, 2026 | 49.35 |
| September 28, 2026 | 49.70 |
| September 25, 2026 | 49.24 |
| September 24, 2026 | 49.65 |
| September 23, 2026 | 49.71 |
| September 22, 2026 | 50.72 |
| September 21, 2026 | 51.08 |
| September 18, 2026 | 50.22 |
| September 17, 2026 | 51.06 |
| September 16, 2026 | 50.29 |
| September 15, 2026 | 50.01 |
| September 14, 2026 | 50.05 |
| September 11, 2026 | 48.13 |
| September 10, 2026 | 48.12 |
| Date | Value |
|---|---|
| September 09, 2026 | 48.63 |
| September 08, 2026 | 48.54 |
| September 04, 2026 | 49.89 |
| September 03, 2026 | 50.87 |
| September 02, 2026 | 50.44 |
| September 01, 2026 | 50.66 |
| August 31, 2026 | 50.25 |
| August 28, 2026 | 50.82 |
| August 27, 2026 | 50.27 |
| August 26, 2026 | 51.43 |
| August 25, 2026 | 52.07 |
| August 24, 2026 | 51.78 |
| August 21, 2026 | 52.41 |
| August 20, 2026 | 51.96 |
| August 19, 2026 | 52.88 |
| August 18, 2026 | 51.15 |
| August 17, 2026 | 50.28 |
| August 14, 2026 | 49.52 |
| August 13, 2026 | 50.00 |
| August 12, 2026 | 49.85 |
| August 11, 2026 | 50.44 |
| August 10, 2026 | 51.69 |
| August 07, 2026 | 52.49 |
| August 06, 2026 | 51.70 |
| August 05, 2026 | 51.00 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AstraZeneca PLC | 166.47 |
| Johnson & Johnson | 252.91 |
| Eli Lilly & Co. | 1255.43 |
| Merck & Co., Inc. | 145.38 |
| Novo Nordisk A/S | 39.23 |